The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
L | Antineoplastic and immunomodulating agents | |
2
|
L01 | Antineoplastic agents | |
3
|
L01B | Antimetabolites | |
4
|
L01BC | Pyrimidine analogues | |
5
|
L01BC06 | Capecitabine |
| Active Ingredient |
|---|
|
Capecitabine is a non-cytotoxic fluoropyrimidine carbamate, which functions as an orally administered precursor of the cytotoxic moiety 5-fluorouracil (5-FU). Capecitabine is activated via several enzymatic steps. |
| Document | Type | Information Source | |
|---|---|---|---|
| ECANSYA Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| KAPETRAL Film-coated tablet | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| XELODA Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.